Back to screener
Showing saved data while refreshing the latest quote and financials…
RE
Sector n/a · Industry n/aSME · NSE Emerge
Remus Pharmaceuticals Limited
REMUSNSE· INE0O5T01011
₹1,911.30
▼ 51.05 (-2.60%) today
Saved quote · Yahoo Finance
Market Cap
₹2.25K Cr
P/E (TTM)
48.8
P/B
5.1
Book Value
₹375.66
ROE
—
Div Yield
—
D/E
—
EPS (TTM)
₹39.16
52W High
₹1,007.00
52W Low
₹580.00
Sales Growth
—
Profit Growth
—
Fundamentals refreshed 2 hr ago · Statements 26 hr ago · Source: Yahoo Finance
Quick Take
- • Trading at 48.8× trailing earnings
- • ROE not reported
- • Leverage not reported
- • No dividend data
- • Operating margin n/a · Net margin n/a
- • Profit growth — YoY · Beta —
Latest quarter · Mar 2026
| ₹ Cr | Mar 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 453 | +30.17% | — |
| Operating Profit | 34 | +25.93% | — |
| Net Profit | 19 | +18.75% | — |
| EPS (₹) | 20.86 | +19.47% | — |
OPM 7.4% · Net margin 4.3% · prev quarter OPM 7.8%
Loading shareholding pattern…
Who is buying / selling · last 12 months (NSE)
| Date | Party | Type | Side | Qty | Price |
|---|---|---|---|---|---|
| 7 Aug 26 | Blue Lotus Capital Multi Bagger Fund Ii | Bulk deal | SELL | 63,900 | ₹830.19 |
| 12 Jan 26 | Alkaben Dipakkumar Shah | Insider · Promoter Group | Buy | 2,600 | ₹708.65 |
| 29 Dec 25 | Arpit Deepakkumar Shah | Insider · Promoters | Buy | 1,200 | ₹737.20 |
| 23 Dec 25 | Renosen Pharmaceuticals Private Limited | Insider · Promoter Group | Buy | 500 | ₹751.58 |
| 15 Dec 25 | Dhruvalben V Shah | Insider · Promoter Group | Buy | 500 | ₹721.00 |
| 12 Dec 25 | Vinodkumar Gandalal Shah | Insider · Promoter Group | Buy | 500 | ₹723.37 |
| 1 Oct 25 | Renosen Pharmaceuticals Private Limited | Insider · Promoter Group | Buy | 200 | ₹730.00 |
| 23 Sept 25 | Roma Vinodbhai Shah | Insider · Promoters | Buy | 3,000 | ₹800.00 |
Insider rows show holding change 0.00% → 0.02% for the latest filing.
About the company
From latest AR & concall Reading the latest annual report and earnings call… (1–3 min on first visit)
